Novaturas Capital Increase, Shareholder Meeting

Novaturas held a repeated Annual General Meeting of Shareholders on June 12, 2026, after the initial meeting on May 27, 2026, failed due to a lack of quorum. During the repeated meeting, shareholders approved the company's audited annual and consolidated financial statements for 2025, consented to the remuneration report, and approved the profit distribution for 2025. A significant decision was the approval to increase the authorized capital from EUR 234,210 to EUR 675,386.46 by issuing up to 14,705,882 new ordinary registered shares. The issue price for these new shares was set at EUR 0.68, representing a 30% discount to the average weighted market price. The company also decided to amend its Articles of Association to reflect the capital increase and to initiate the listing and trading of the new shares on Nasdaq Vilnius and the Aquis Stock Exchange. Notably, the decision to revoke shareholders' pre-emptive rights to acquire new shares was not adopted, meaning existing shareholders will have a pre-emptive right. The biggest shareholder, Neşet Koçkar, is entitled to subscribe for any unsubscribed new shares. Additionally, Gediminas Almantas, Chairman of the Board, was granted an additional one-time remuneration of EUR 29,000.